Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.47% Nasdaq Up0.38%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

12.32 Up 1.83(17.45%) Mar 8, 4:00PM EST|After Hours : 12.19 Down 0.13 (1.06%) Mar 8, 5:24PM EST

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 9,265   46,793   15,180  
Cost of Revenue -   -   -  
Gross Profit 9,265   46,793   15,180  
Operating Expenses
Research Development32,439  27,650  26,169  
Selling General and Administrative9,243  10,428  17,119  
Non Recurring9,119  12,077  8,397  
Others1,913  3,143  949  
Total Operating Expenses52,714  53,298  52,634  
Operating Income or Loss (43,399) (6,455) (36,850)
Income from Continuing Operations
Total Other Income/Expenses Net446  5,309  852  
Earnings Before Interest And Taxes(43,003)(1,196)(36,602)
Interest Expense1,796  1,337  452  
Income Before Tax(44,799)(2,533)(37,054)
Income Tax Expense -   -  (529)
Minority Interest -   -   -  
Net Income From Continuing Ops(44,799)(2,533)(36,525)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (44,799) (2,533) (36,525)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (44,799) (2,533) (36,525)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.